[9,10] Prescribing patterns of antihypertensive were classified into two types like with comorbidities 38%, and without comorbidities 62%. Among these comorbidities Cerebrovascular Accident Hemiplegia 21%, Diabetic Mellitus 13%, inhibitor purchase Diabetic Mellitus + Hemiplegia 4%. CONCLUSION Our study shows that the most commonly prescribed drug classes involved were Calcium Channel Blockers followed by Angiotensin II receptor antagonists and the anti-hypertensive drug combinations among hypertensive patients were considerable and this practice positively impacted on the overall blood pressure control. In order to promote the rational prescribing drugs and hospital formularies in special committees are useful in reducing the misuse of drugs especially in poly-pharmacy and in the treatment of hypertension.

Footnotes Source of Support: Nil. Conflict of Interest: None declared.
India has the largest pool of patients suffering from cancer, diabetes, metabolic syndrome, and other maladies. Furthermore, due to low costs, medical expertise and good hospital facilities, many Multinational Companies are conducting several trials in India recruiting several thousands of Indians.[1] Several articles talk about increase in number of clinical trials (CTs) and revenues but few talks about ??Trial Participants (TPs)?? who contribute to the advancement of science and to the revenue. Few researchers have looked at whether the TPs who get recruited in CTs are aware of what CTs are and if participation agreement is purely their conscious decision.

Studies have made known that fear, distrust or suspicion of research, apprehension and scepticism could hinder awareness about the CTs, especially among minorities.[2] Language and literacy barriers may make it difficult for some people to understand which may be the main barrier for awareness. In the west, studies have been carried out with cancer patients about AV-951 their awareness of CTs mainly because of recruitment difficulties but few researchers have tried to find out general public awareness of CTs. In India, it is hard to find literature on such topics. Thus, this study has used references from the west. A study conducted with South Asian Patients in Briton had identified motivators for participating in the trials as, improve own as well as family and friend’s health, help to the society and increase in scientific knowledge.[3] The same study had reported the deterrents as concerns of drug side effects, language barriers, previous bad experiences, mistrust and feeling of not belonging to British society.[3] Another all targets study by Hussan-Gambles reported barriers to participate in CT were trial burden, mistrust with health workers and language barriers.